Should there be a fracas over FRAX and other fracture prediction tools?: Comment on "A comparison of prediction models for fractures in older women".
作者信息
Colón-Emeric Cathleen S, Lyles Kenneth W
机构信息
Duke University Medical Center, Durham, NC 27710, USA.
出版信息
Arch Intern Med. 2009 Dec 14;169(22):2094-5. doi: 10.1001/archinternmed.2009.2094.
Abstract
摘要
相似文献
1
Should there be a fracas over FRAX and other fracture prediction tools?: Comment on "A comparison of prediction models for fractures in older women".
Arch Intern Med. 2009 Dec 14;169(22):2094-5. doi: 10.1001/archinternmed.2009.2094.
2
Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102.
3
A comparison of prediction models for fractures in older women: is more better?
Arch Intern Med. 2009 Dec 14;169(22):2087-94. doi: 10.1001/archinternmed.2009.404.
4
Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
Arch Osteoporos. 2020 Oct 16;15(1):163. doi: 10.1007/s11657-020-00837-x.
5
Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
J Am Med Dir Assoc. 2014 Dec;15(12):918-23. doi: 10.1016/j.jamda.2014.07.011. Epub 2014 Sep 24.
6
Assessment of individual fracture risk: FRAX and beyond.
Curr Osteoporos Rep. 2010 Sep;8(3):131-7. doi: 10.1007/s11914-010-0022-3.
7
Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
Menopause. 2012 Nov;19(11):1193-9. doi: 10.1097/gme.0b013e31825d65c5.
8
Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
Bone. 2013 Sep;56(1):16-22. doi: 10.1016/j.bone.2013.05.002. Epub 2013 May 10.
9
Beyond FRAX: it's time to consider "sarco-osteopenia".
J Clin Densitom. 2009 Oct-Dec;12(4):413-6. doi: 10.1016/j.jocd.2009.06.004. Epub 2009 Sep 3.
10
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28.
引用本文的文献
1
Exploration of the Immuno-Inflammatory Potential Targets of Xinfeng Capsule in Patients with Ankylosing Spondylitis Based on Data Mining, Network Pharmacology, and Molecular Docking.
Evid Based Complement Alternat Med. 2022 Mar 23;2022:5382607. doi: 10.1155/2022/5382607. eCollection 2022.
2
Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.
Osteoporos Int. 2012 Mar;23(3):871-8. doi: 10.1007/s00198-011-1647-5. Epub 2011 May 12.
3
WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?
J Bone Miner Res. 2011 Aug;26(8):1774-82. doi: 10.1002/jbmr.372.
本文引用的文献
1
Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram.
Osteoporos Int. 2010 May;21(5):863-71. doi: 10.1007/s00198-009-1026-7. Epub 2009 Jul 25.
2
Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
Bone. 2009 Jun;44(6):1049-54. doi: 10.1016/j.bone.2009.02.014. Epub 2009 Feb 28.
3
FRAX and its applications to clinical practice.
Bone. 2009 May;44(5):734-43. doi: 10.1016/j.bone.2009.01.373. Epub 2009 Feb 3.
4
Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines.
J Bone Miner Res. 2009 Apr;24(4):675-80. doi: 10.1359/jbmr.081203.
5
Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28.
6
Does a history of non-vertebral fracture identify women without osteoporosis for treatment?
J Gen Intern Med. 2008 Aug;23(8):1177-81. doi: 10.1007/s11606-008-0622-0. Epub 2008 May 6.
7
Cost-effective osteoporosis treatment thresholds: the United States perspective.
Osteoporos Int. 2008 Apr;19(4):437-47. doi: 10.1007/s00198-007-0550-6. Epub 2008 Feb 22.
8
Effects of risedronate on fracture risk in postmenopausal women with osteopenia.
Osteoporos Int. 2008 May;19(5):681-6. doi: 10.1007/s00198-007-0493-y. Epub 2007 Oct 30.
9
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study.
J Bone Miner Res. 2007 Jan;22(1):135-41. doi: 10.1359/jbmr.061008.
10
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.
N Engl J Med. 2001 Feb 1;344(5):333-40. doi: 10.1056/NEJM200102013440503.
Zotero 插件